Glycine betaine and its use as anti-hemorrhagic agent

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/205 (2006.01) A61K 45/06 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2441948

A pharmaceutical combination comprising a therapeutic effective amount of a therapeutically active agent with at least one haemorrahgic side effect, and a therapeutic effective amount of a compound of formula (CH3)3N+(CH2)nCOO- with n an integer from 1 to 5 for preventing or reducing said haemorrahgic side effect.

L'invention porte sur une combinaison pharmaceutique contenant une quantité thérapeutiquement efficace d'un agent thérapeutiquement actif ayant au moins un effet secondaire hémorragique, et sur une quantité thérapeutiquement efficace d'un composé représenté par la formule (CH¿3?)¿3?N?+¿(CH¿2?)¿n?COO?-¿, n étant un nombre entier compris entre 1 et 5, et utilisé dans la prévention ou l'atténuation dudit effet secondaire hémorragique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glycine betaine and its use as anti-hemorrhagic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycine betaine and its use as anti-hemorrhagic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycine betaine and its use as anti-hemorrhagic agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1895375

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.